220 related articles for article (PubMed ID: 37894912)
1. Rational Design, Synthesis and Binding Affinity Studies of Anthraquinone Derivatives Conjugated to Gonadotropin-Releasing Hormone (GnRH) Analogues towards Selective Immunosuppression of Hormone-Dependent Cancer.
Biniari G; Markatos C; Nteli A; Tzoupis H; Simal C; Vlamis-Gardikas A; Karageorgos V; Pirmettis I; Petrou P; Venihaki M; Liapakis G; Tselios T
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894912
[TBL] [Abstract][Full Text] [Related]
2. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
[TBL] [Abstract][Full Text] [Related]
3. Novel Crizotinib-GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems.
Murányi J; Varga A; Gyulavári P; Pénzes K; Németh CE; Csala M; Pethő L; Csámpai A; Halmos G; Peták I; Vályi-Nagy I
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717403
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone/gonadotropin-releasing hormone receptor signaling in the placenta.
Sasaki K; Norwitz ER
Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):401-8. PubMed ID: 22024993
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone (GnRH) receptors of cattle aggregate on the surface of gonadotrophs and are increased by elevated GnRH concentrations.
Kadokawa H; Pandey K; Nahar A; Nakamura U; Rudolf FO
Anim Reprod Sci; 2014 Nov; 150(3-4):84-95. PubMed ID: 25301533
[TBL] [Abstract][Full Text] [Related]
6. Receptor-mediated targeting of a photosensitizer by its conjugation to gonadotropin-releasing hormone analogues.
Rahimipour S; Ben-Aroya N; Ziv K; Chen A; Fridkin M; Koch Y
J Med Chem; 2003 Sep; 46(19):3965-74. PubMed ID: 12954050
[TBL] [Abstract][Full Text] [Related]
7. The role of GnRH metabolite, GnRH-(1-5), in endometrial cancer.
Cho-Clark MJ; Watkins A; Wu TJ
Front Endocrinol (Lausanne); 2023; 14():1183278. PubMed ID: 37124730
[TBL] [Abstract][Full Text] [Related]
8. Refinement of the gonadotropin releasing hormone receptor I homology model by applying molecular dynamics.
Tzoupis H; Nteli A; Platts J; Mantzourani E; Tselios T
J Mol Graph Model; 2019 Jun; 89():147-155. PubMed ID: 30889428
[TBL] [Abstract][Full Text] [Related]
9. Luteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomes.
He Y; Zhang L; Song C
Int J Nanomedicine; 2010 Sep; 5():697-705. PubMed ID: 20957221
[TBL] [Abstract][Full Text] [Related]
10. Bifunctional gonadotropin-releasing hormone antagonist-progesterone analogs with increased efficacy and duration of action.
Ratcliffe KE; Fraser HM; Sellar R; Rivier J; Millar RP
Endocrinology; 2006 Jan; 147(1):571-9. PubMed ID: 16223868
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-Releasing Hormone and GnRH Receptor: Structure, Function and Drug Development.
Tzoupis H; Nteli A; Androutsou ME; Tselios T
Curr Med Chem; 2020; 27(36):6136-6158. PubMed ID: 31309882
[TBL] [Abstract][Full Text] [Related]
12. Influences of hydrocarbon linkers on the receptor binding affinities of gonadotropin-releasing hormone peptides.
Guo H; Hathaway H; Royce ME; Prossnitz ER; Miao Y
Bioorg Med Chem Lett; 2013 Oct; 23(20):5484-7. PubMed ID: 24018188
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and systematic comparison of FITC-labelled GnRH-I, -II and -III analogues on various tumour cells.
Murányi J; Gyulavári P; Varga A; Bökönyi G; Tanai H; Vántus T; Pap D; Ludányi K; Mező G; Kéri G
J Pept Sci; 2016 Aug; 22(8):552-60. PubMed ID: 27443981
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients?
Montagnani Marelli M; Moretti RM; Januszkiewicz-Caulier J; Motta M; Limonta P
Curr Cancer Drug Targets; 2006 May; 6(3):257-69. PubMed ID: 16712461
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro biological evaluation of daunorubicin containing GnRH-I and GnRH-II conjugates developed for tumor targeting.
Szabó I; Bősze S; Orbán E; Sipos É; Halmos G; Kovács M; Mező G
J Pept Sci; 2015 May; 21(5):426-35. PubMed ID: 25908176
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro stability, and antiproliferative effect of d-cysteine modified GnRH-doxorubicin conjugates.
Li S; Zhao H; Chang X; Wang J; Zhao E; Yin Z; Mao X; Deng S; Hao T; Wang H; Yang Y
J Pept Sci; 2019 Jan; 25(1):e3135. PubMed ID: 30467919
[TBL] [Abstract][Full Text] [Related]
17. Introduction of D-phenylalanine enhanced the receptor binding affinities of gonadotropin-releasing hormone peptides.
Lu J; Hathaway HJ; Royce ME; Prossnitz ER; Miao Y
Bioorg Med Chem Lett; 2014 Feb; 24(3):725-30. PubMed ID: 24418777
[TBL] [Abstract][Full Text] [Related]
18. Chitosan-based DNA delivery vector targeted to gonadotropin-releasing hormone (GnRH) receptor.
Boonthum C; Namdee K; Boonrungsiman S; Chatdarong K; Saengkrit N; Sajomsang W; Ponglowhapan S; Yata T
Carbohydr Polym; 2017 Feb; 157():311-320. PubMed ID: 27987933
[TBL] [Abstract][Full Text] [Related]
19. Presence of immunoreactive gonadotropin releasing hormone (GnRH) and its receptor (GnRHR) in rat ovary during pregnancy.
Sengupta A; Chakrabarti N; Sridaran R
Mol Reprod Dev; 2008 Jun; 75(6):1031-44. PubMed ID: 17935160
[TBL] [Abstract][Full Text] [Related]
20. New derivatives of GnRH as potential anticancer therapeutic agents.
Mezo G; Manea M; Szabí I; Vincze B; Kovács M
Curr Med Chem; 2008; 15(23):2366-79. PubMed ID: 18855666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
